No Images? Click here ![]() ACMT CONNECTION E-News: DECEMBER 2018 New Position Statement on Buprenorphine ACMT supports the administration of buprenorphine in the ED as a bridge to long-term addiction treatment. Our Position Statements and Guidelines Committee published 'Buprenorphine Administration in the Emergency Department' on Dec. 12. Make Your 2018 Annual Campaign Donation MTF has funded more than $205,000 in grants and travel awards to Medical Toxicologists. Help us exceed our 2018 Annual Campaign goal of $70,000 in ACMT member donations! Read about award recipients and how they are using MTF funding to advance the field. ![]() $50,000 Grant Received for Opioid Treatment Education MTF received $50,000 in support from the Independence Blue Cross Foundation under the Supporting Treatment and Overdose Prevention (STOP) program. These funds will support Curbing the Opioid Crisis in Philadelphia: Increasing Emergency Department Initiation of Buprenorphine-Naloxone Treatment for Opioid Use Disorder initiative. ![]() PI: Jeanmarie Perrone, MD, FACMT Member Leadership Update Congratulations to new ACMT Executive Committee member:
Congratulations to new and continuing Board of Directors elected members:
2018 ACMT Year in Review Executive Director Paul Wax, MD, FACMT, shares highlights from the year, including successful conferences, ACMT's 25th Anniversary, and milestone staff anniversaries. ![]() 2019 MTF Awards and Grants Innovative Research and Teaching Award: Request grant dollars from $5,000—$20,000! Join us at a submission planning webinar on Jan. 8 at 1pm EST. Applications due Feb. 15, 2019. MTF/EMF Research Grant: Request a $10,000 grant! Applications due Feb 28, 2019 Register Today: 2019 ACMT Annual Scientific Meeting and Satellite Sessions We are hosting TWO Satellite Sessions on April 11:
Early Bird deadline is Feb. 1! PEHSU National Classroom - New Learning Opportunities Enroll in PEHSU webinars anytime! New classes include:
January Tweetchat Join us at #firesidetox on Jan. 15 at 3:00pm EST to discuss the ACMT Position Statement: Alternative or Contingency Countermeasures for Acetylcholinesterase Inhibiting Agents |